Marc Beer Gets an Executive Role at a Leading Pharmaceutical Company

Marc Beer is a respected entrepreneur and administrator in the world’s health sector. He is esteemed for starting, developing, and managing some of the most successful pharmaceutical companies based in the United States.

In April 2019, LumeNXT, a private company that manufactures surgical devices appointed Marc Beer to supervise its board of directors. LumeNXT’ co-founder said that the seasoned entrepreneur and administrator would help LumeNXT to achieve its goals.

“We are privileged to receive Marc Beer as the chairman of our board of directors. Mr. Beer is a talented administrator who has managed and developed multiple start-ups. His vast experience would position our company on the right path to profitability,” said Paul Rhyne, a senior executive at LumeNXT.

In response to Paul Rhyne’s statement, Mr. Beer said that he was pleased to join LumeNXT’s team. “I have confidence that our collaboration would help LumeNXT to develop more medical products that would be used to enhance the safety and precision of surgical operations,” said Marc Beer.

Already, LumeNXT has launched medical devices used to improve surgical visualization and surgical precision. Moreover, the LumeNXT’s solutions boost workflow efficiency within surgical operation rooms.

Why did LumeNXT hire Marc Beer? LumeNXT’s co-founder disclosed that they appointed Marc Beer since he has over 25 years of innovative and managerial involvement in the world’s pharmaceutical sector.

Mr. Beer is a founding executive of Renovia Inc., one of the leading startups in the world’s biopharmaceutical sector. Renovia develops diagnostic and therapeutic medical solutions used to treat millions of people living with conditions resulting from debilitated pelvic floor muscles. Mr. Beer has been leading the company since 2016.

Before starting Renovia, Marc co-founded and managed several companies. He worked as an executive director at Minerva Neurosciences, a pharmaceutical company that develops therapeutic options used to manage depression, Parkinson’s disease, Insomnia, stress, and other mental disorders.

In 2007, Marc Beer worked as the founding chairperson of Good Start Genetics, a company that develops medical solutions used in surgery, medical oncology, and gynecology. Furthermore, the company develops medical solutions used in IVF, urology, cardiology, and pediatrics. Invitae acquired Good Start Genetics.

Learn more: https://renoviainc.com/leadership/

 

Marc Beer Takes On The Role Of Chairman Of The Board At LumeNXT

In a recent announcement, LumeNXT noted the appointment of Marc Beer as the company’s new Chairman of the Board. LumeNXT is a private company that specializes on developing a surgical illumination product line designed for surgeries that have a minimally invasive approach. The company focuses on pioneering the use of intracavity LED illumination, its illumination platform being used as a mechanism designed to improve workflow efficiency, precision, and also safety via visualization. According to surgeons that have used targeted illumination, they find the technology is able to enhance visualization, precision, and flexibility during operations.

Marc Beer, the newly appointed Chariman of the Board of LumeNXT, has a career in the field of healthcare spanning more than 25 years. He has experience in areas concerning commercialization and development in fields such as pharmaceuticals, biotechnology, devices, and diagnostics. Beer stated that he believes the importance of the company’s illumination platform will continue to increase, as more surgeries are being performed using minimally invasive techniques. He also noted that he is proud to be working with the company’s group of engineers and surgeons, describing them as being accomplished and dedicated, and being responsible for advancing the field of surgical illumination by using the company’s proprietary technology.

LumeNXT’s co-found, Paul Rhyne, also had something to say about the new Chairman of the Board, pointing out that Marc Beer has shown high levels of success in a number of startup companies, as he guided them through multiple growth phases. The co-founder also stated that Beer’s experience when it comes to starting companies and guiding them to profitability is valued at LumeNXT, as the company continues to grow.

Besides his new role at LumeNXT, Marc Beer is also at the helm of Renovia, Inc. a company that he co-founded in August of 2016, where he serves as Chief Executive Officer. The company focuses on discovering and delivering digital therapeutic and diagnostic devices designed to help those who are affected by pelvic floor disorders. In addition, throughout his career spanning a quarter of a century, Beer has been involved with many organizations within the healthcare segment, having various roles.

Beer was the Founding CEO at ViaCell, a role he took in April of 2000. ViaCell was a biotechnology company that focused on umbilical cord blood stem cells, and under Beer’s leadership the company grew to have 300 employees and became a publicly traded company in 2005, before being ultimately acquired by PerkinElmer, 2 years later. During his 7-year stint at ViaCell, Beer was also a member on the board of directors at Erytech Pharma, a biopharmaceutical company. He was also involved with Genzyme during his career, serving as Vice President of Global Marketing, and also with organizations such as Abbott Laboratories and Minerva Neurosciences, among others. Learn more: https://www.bizjournals.com/boston/potmsearch/detail/submission/6457372/Marc_Beer

“Marc Beer Using Renovia Inc. to Solve Women Health Issues “

Just like many startup companies in the United States, Renovia Inc. is a medical organization that was co-founded by Marc Beer to help women deal with pelvic floor disorder and other diseases affecting women. It is common knowledge that women are the most vulnerable demographic in the United States and other parts of the world, especially when health is concerned. Marc Beer has the vision of developing various products that could play a vital role in enhancing the quality of life among women. One of the major drives towards the formation of Renovia Inc. is pelvic floor disorder, a disease that is affecting more than 250 million around the world.

Renovia Inc. wants to utilize the current technology to come up with modern devices that can provide solutions to existing problems. The main aspect of using the current technology is to ensure that that the solution realized will be useful to those affected by the disease. It is also apparent that a considerable number of individuals are finding the current medical costs to be too high to handle. Renovia Inc. wants to develop a technology that makes it easy for different people to access. Current data show that only a few numbers of people can be able to access the treatment of pelvic floor disorders.

One of the standout product that has already been developed by Renovia Inc. is the Leva Pelvic Digital Health, which is a platform that helps those affected by the illness to leverage on the available treatment options. This is a medical advancement that is very useful in eradicating stress while at the same time encouraging women to seek therapeutic solutions from medical experts in the industry. Studies show that a considerable number of women, especially those with pelvic floor disorders don’t find medical solutions because of costs while others have a perception that their privacy is intruded.

However, leveraging on the technology that has been brought about by Renovia Inc. protects all women. Besides, it lowers the cost of medication, which means that any person can easily access treatment. These technology is helping in strengthening pelvic muscles while at the same time relieving incontinence and other symptoms such as excessive urinary frequency. Renovia Inc. is expected to be a game changer in this industry as most of its technical devices have already been approved by the FDA, which allows for commercial production of the products. Learn more: 

https://www.crunchbase.com/person/marc-beer

 

About Marc Beer

Marc Beer has all the necessary skills, knowledge, and experience to spearhead the growth of Renovia Inc. He has been in various startups, and his work is visible to all those who work in the medical sector. In his 25 years’ experience, Marc Beer has worked in various companies and medical startups as a sales representative, chief executive officer, and a technology-driven expert who has brought many pharmaceutical products.

 

“How Did Marc Beer Help Renovia Inc. Improve Its Image? “

Marc Beer graduated from Miami University with a degree in Science. With 25 years of experience in diagnostics, biotechnology, devices, and pharmaceuticals he co-founded Renovia Inc. Renovia is one of the long-string success of Marc Beer who has created a track record which touches most of the essential convergences of medicine and technology. He is considered an optimal leader for Renovia due to the success of the organization.

 

Most recently, Marc Beer and his team raised $42-million that will be used by Renovia to support clinical trials corporate development, future commercial launches, and product development pipeline. The funds will go into developing therapeutic devices and diagnostic for treating pelvic disorders among women. The company will test and produce four more products for treating pelvic disorders. The Leva pelvic digital health system is one of the launches of Renovia. Since the development of the system, there has not been any changes or upgrades to it.

 

The current generation Leva allows a flexible probe to be placed in the Vagina which stays there during exercises. It is then connected to a transmitter which uses Bluetooth technology while sending data to the Leva smartphone app. The system has sensors that allow users to track the position of the pelvic floor muscles including their movement created during exercises. Pelvic floor muscles resemble muscles found in the body meaning that they can be strengthened and worked out over time. Learn more: 

https://www.bizjournals.com/boston/potmsearch/detail/submission/6457372/Marc_Beer

 

 

The exercises need to follow the correct steps to make the process work. For women suffering from pelvic floor disorders, this is easier said than done. It is beneficial when women are seeing what is taking place on the screen. In addition, the device stores information concerning the previous training sessions which can be used by users to track progress and at the same time ensure that the exercises are performed regularly.

 

Marc Beer and his team believe that in future there will be breakthroughs in the healthcare system and there will be no need of putting systemic med into the body of women suffering from pelvic floor disorder. They will also stop using sensors to monitor activities, but they will use the sensors in unique ways. Marc Beer believes that the company is a leader when it comes to women’s healthcare and this is because they have already made a breakthrough regarding the peripheral vascular disease, pain management, and cardiac disorders.

 

The advice that Marc Beer often gives to potential entrepreneurs is that they should focus their attention on innovation and staying focused on great value to succeed in their ventures. He urges them not to think of taking any shortcuts.

 

 

“Businessman Marc Beer Raises Mammoth Sum for Women’s Health “

For most who undertake them, fundraisers are often a tricky venture. Simply raising awareness of one’s cause can be exhaustive, physically and monetarily. Massive amounts of business, and make no mistake, fundraising is a business, are done on the internet these days. Without creativity, excellent timing, and a dash of luck, even the noblest of intentions can fail miserably.

 

Fortunately for women in the city of Boston, Marc Beer refused to take “no” for an answer.

 

For over a quarter of a century, Marc has excelled as an executive working at numerous companies; most were involved in biotechnological or pharmaceutical endeavors.

 

The fundraising he’s conducted is no different. One of his latest initiatives, Marc has involved himself in a fundraising project for a startup company (Renovia, Inc.) focused on increasing the awareness of, and potential to provide treatment for cases of a plethora of disorder of the pelvic region most commonly associated with women. The total amount of funds he’s helped accumulate is approximately 42 million dollars. Many researchers conclude that typical startup costs can range from $3,000 to over $100,000. With Marc’s typically zeal for high performance, it’s clear that he’s more than exceeded the average threshold. This will allow him to further refine the technology being applied in order to diagnose and treat illnesses affecting the pelvic floor region. As per the Cleveland Clinic, the pelvic floor is a region of the body in which are contained the organs necessary to facilitate a proper bowel movement. Dysfunction in this region is often characterized by inability to regulate the majority of the tightening and relaxing conducted by muscle fibers. Learn more: 

https://patch.com/massachusetts/boston/renovias-marc-beer-raises-42m-treat-womens-health-issues

 

 

Marc Beer’s credibility is untouchable after dozens of years in executive positions in businesses whose fields pertain directly and indirectly to the maintenance and improvement of technology designed to improve the quality of life. This drive is combined with the savvy to keep financial operations functional while pursuing groundbreaking processes which can and will serve generations for years to come. It is safe to say that this will not be the last milestone achieved by the ambitious and dedicated Mr. Beer.

 

 

Marc Beers’ Newest Round Of Funding For Renovia Attracts $42 Million

In the new round of funding, Marc Beer led his new startup Renovia Inc.to attracts over $42 million. The funding was in two parts with the Series B round bringing in $32 million and the $10 million streaming in as venture debt. According to Marc, these funds will play a key role in advancing the research and development of different treatment techniques in the field of biotechnology and pharmaceutical devices and diagnostics.

 

Currently, his medical technology company has concentrated its efforts on the development of a diagnosis and treatment of urinary incontinence. This refers to a pelvic floor disorder that the company estimated to affect over 250 million women over the world. A significant percentage of the funds collected during this round will, therefore, be dedicated to developing more advanced diagnostic technologies and more effective treatment options.

 

Other leading innovations by Renovia

 

Apart from the pelvic treatment option, the technology company has several other equally innovative medical treatments options in the pipeline. Some like Leva, the company’s first product have already received the approved for commercialization and global distribution by the Food and Drug Administration (FDA). Marc is also optimistic that the infusion of these finances will help speed up the development and testing process for four new products his startup has been working on as well as the production of an advanced and new generation of Leva.

 

Renova’s approach to medical innovations

 

Renovia hopes to offer to add a new twist to the development of treatment options by infusing medical technology and customer data. According to Marc Beer, this approach goes a long way in ensuring that Renovia only develops the most useful and relevant treatments by way of appealing the most to the public.

 

More about Marc Beer

 

Over the past 25 years, Marc Beer has dedicated his time to the development and commercialization of pharmaceuticals, innovative diagnostics, and biotechnological devices. He is, therefore, well exposed and experienced in overseeing the entire drug development process right from the research to the commercialization stage. Before co-founding Renovia Inc. with Ramon Iglesias in 2016, he had started and run several other successful medical technologies companies in addition to serving in the boards of leading medieval technology firms in the country.

 

Marc made his first major move in the biotechnology industry when he started ViaCell Company that specialized in the collection and preservation of umbilical cord stem cells. He served as the company’s Chief executive officer and oversaw its rapid growth that reached 300 employees in 2005 before leading its acquisition by PerkinElmer in 2007.

 

He has also served in the boards of such companies as Erytech Pharma and Abbott Laboratories. His most recent high profile role was serving as a vice president of Genzyme’s Global marketing division where he helped the brand launch several medications for rare diseases. Learn more: https://renoviainc.com/